CVS Health Corp. buy Wolfe Research
Summary
This prediction is currently active. The BUY prediction by Wolfe_Research shows slight gains of 7.41%. Dividends of €0.57 are taken into consideration when calculating the performance. This prediction currently runs until 12.09.24. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| CVS Health Corp. | 10.867% | 10.867% |
| iShares Core DAX® | 2.122% | 10.227% |
| iShares Nasdaq 100 | 1.636% | 4.583% |
| iShares Nikkei 225® | -0.215% | 3.810% |
| iShares S&P 500 | 1.321% | 4.686% |
Comments by Wolfe_Research for this prediction
In the thread CVS Health Corp. diskutieren
